TONIX Pharmaceuticals, Inc. To Present At The Oppenheimer Healthcare Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, Nov. 26, 2013 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, will be presenting at the 24th Annual Oppenheimer Healthcare Conference in New York City. Seth Lederman, M.D., president and CEO of Tonix, will deliver a corporate overview on Tuesday, December 10, 2013 at 3:55 PM ET.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC